Ceres Group Aktie
WKN DE: 924055 / ISIN: US1567721055
22.11.2005 21:15:00
|
Ceres Group to Present at the Friedman, Billings, Ramsey & Co. 12th Annual Investor Conference
Investors will be able to access the presentation via the FBRwebsite at www.fbr.com. The direct link to the registration page ishttp://www.wsw.com/webcast/fbr13/cerg/. Following the live webcast, areplay of the presentation will be available for 90 days. Mr. Kilian'spresentation will also be available on the Ceres website atwww.ceresgp.com.
About Ceres Group
Ceres Group, Inc., through its insurance subsidiaries, provides awide array of health and life insurance products through two primarybusiness segments. Ceres' Medical Segment includes major medicalhealth insurance for individuals, families, associations and smallbusinesses. The Senior Segment includes senior health, life andannuity products for Americans age 55 and over. To help controlmedical costs, Ceres also provides medical cost management services toits insureds. Ceres' nationwide distribution channels includeindependent and career agents, as well as electronic distributionsystems. Ceres is included in the Russell 3000(R) Index. For moreinformation, visit www.ceresgp.com.
This news release contains certain forward-looking statements withrespect to the financial condition, results of operations and businessof the company. Forward-looking statements are statements other thanhistorical information or statements of current condition. In light ofthe risks and uncertainties inherent in all future projections, theinclusion of forward-looking statements herein should not be regardedas representation by the company or any other person that theobjectives or plans of the company will be achieved. Many factorscould cause actual results to differ materially from thosecontemplated by such forward-looking statements, including, amongothers, failure to accurately predict loss ratios and improvements inour business, business conditions and competition in the healthcareindustry, the failure to successfully implement the business plans(including the company's growth strategy) for the company and itssubsidiaries, failure to accurately predict claims liabilities,ability to institute necessary rate increases, ability to develop,market and administer new and competitive products, developments inhealthcare reform and other regulatory issues (including failure tomeet statutory capital requirements), rising healthcare costs, adverseoutcomes in litigation and related matters, failure to comply withfinancial and other covenants in our loan agreement, and performanceof our reinsurers. This review of important factors should not beconstrued as exhaustive. Investors and others should refer to Ceres'filings with the Securities and Exchange Commission, including itsannual report on Form 10-K for the year ended December 31, 2004, andits quarterly reports on Form 10-Q and other periodic filings, for adescription of the foregoing and other factors. Ceres undertakes noobligation to update forward-looking statements to reflect events orcircumstances after the date hereof or to reflect the occurrence ofunanticipated events.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Ceres Group Inc.mehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Ceres Group Inc.mehr Analysen
Indizes in diesem Artikel
NASDAQ Comp. | 18 188,59 | 2,27% |